Compare Humana Inc (HUM) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Exxon Mobil Corporation — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Exxon Mobil Corporation trades at $159.7 (market cap $634.34B). The key difference: Exxon Mobil Corporation is far larger — about 13.7× Humana Inc's market cap, and Exxon Mobil Corporation pays the higher dividend (2.69%). Which is the better fit depends on your goals.
| HUM | XOM | |
|---|---|---|
Market Cap | $46.31B | $634.34B |
Sector | Health | Energy |
52-Week High | $409.42 | $171.52 |
52-Week Low | $163.67 | $105.83 |
Enterprise Value | $53.67B | $673.57B |
Dividend Yield | 0.92% | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
ExxonMobil (XOM) trades at $152.94, down 1.22% on the day, with a bullish technical signal from moving averages but neutral oscillators. Revenue declined to $323.91B in 2025, with net income at $28.84B, while the P/E ratio stands at 25.76. Recent news highlights Exxon's Permian Basin advantages and warnings of potential oil price spikes to $160 per barrel amid Middle East tensions.
Outlook is mixed: strong cash flow and low breakeven costs support dividends, but falling profit margins and net cash outflows pose risks. Analyst consensus is a buy with a $163.71 price target, though geopolitical volatility and energy transition pressures remain key concerns for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
